ABN AMRO Bank N.V. Takes $937,000 Position in The Ensign Group, Inc. $ENSG

Key Points

• ABN AMRO Bank acquired 5,858 shares of The Ensign Group worth approximately $937,000, while institutional investors collectively own 96.12% of the company.
• Analyst sentiment remains positive overall, with four Buy ratings and two Holds producing a consensus “Moderate Buy” rating and an average price target of $216.25.
• The Ensign Group exceeded quarterly earnings expectations, reporting $1.92 in EPS versus the $1.80 consensus, while revenue rose 16.7% year over year to $1.44 billion. The company also paid a quarterly dividend of $0.065 per share.

ABN AMRO Bank N.V. purchased a new position in The Ensign Group, Inc. (NASDAQ:ENSG - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,858 shares of the company's stock, valued at approximately $937,000.

Several other institutional investors have also made changes to their positions in the stock. Mitsubishi UFJ Trust & Banking Corp increased its position in The Ensign Group by 52.5% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 54,336 shares of the company's stock worth $9,465,000 after purchasing an additional 18,699 shares during the last quarter. Sanctuary Advisors LLC lifted its holdings in shares of The Ensign Group by 594.9% during the 4th quarter. Sanctuary Advisors LLC now owns 24,510 shares of the company's stock valued at $4,270,000 after buying an additional 20,983 shares during the last quarter. NewEdge Wealth LLC acquired a new stake in shares of The Ensign Group during the 4th quarter valued at about $5,224,000. Norges Bank bought a new stake in shares of The Ensign Group in the 4th quarter valued at approximately $134,660,000. Finally, Mawer Investment Management Ltd. grew its stake in shares of The Ensign Group by 15.8% in the 4th quarter. Mawer Investment Management Ltd. now owns 126,186 shares of the company's stock valued at $21,982,000 after buying an additional 17,225 shares in the last quarter. 96.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Weiss Ratings lowered shares of The Ensign Group from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday, June 16th. Truist Financial boosted their target price on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a "hold" rating in a research report on Thursday, July 30th. Wall Street Zen lowered shares of The Ensign Group from a "buy" rating to a "hold" rating in a research note on Saturday, July 25th. Finally, Royal Bank Of Canada restated an "outperform" rating and set a $228.00 price target on shares of The Ensign Group in a report on Tuesday, July 28th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, The Ensign Group presently has an average rating of "Moderate Buy" and a consensus target price of $216.25.

Insider Buying and Selling

In other news, Director Barry M. Smith sold 700 shares of the business's stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the sale, the director directly owned 21,352 shares in the company, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the company's stock in a transaction on Monday, July 20th. The shares were sold at an average price of $171.06, for a total value of $67,055.52. Following the completion of the transaction, the director owned 9,503 shares of the company's stock, valued at $1,625,583.18. The trade was a 3.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 4.00% of the company's stock.

The Ensign Group Trading Down 0.1%

Shares of ENSG stock opened at $181.65 on Friday. The firm has a market capitalization of $10.59 billion, a P/E ratio of 28.47, a price-to-earnings-growth ratio of 1.75 and a beta of 0.68. The Ensign Group, Inc. has a 1 year low of $141.58 and a 1 year high of $218.00. The firm's fifty day simple moving average is $168.19 and its 200 day simple moving average is $184.13. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.06.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last issued its quarterly earnings results on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, beating analysts' consensus estimates of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same period in the prior year, the firm earned $1.59 EPS. The business's revenue was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. As a group, sell-side analysts predict that The Ensign Group, Inc. will post 6.93 EPS for the current year.

The Ensign Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th were issued a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend was Tuesday, June 30th. The Ensign Group's dividend payout ratio (DPR) is presently 4.08%.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company's model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source